China Health Group Inc. (HKG:8225)
0.1360
+0.0020 (1.49%)
Apr 17, 2026, 3:39 PM HKT
China Health Group Revenue
In the year 2025, China Health Group had annual revenue of 28.56M CNY with 7.98% growth. China Health Group had revenue of 6.94M in the half year ending December 31, 2025, with 8.50% growth.
Revenue
28.56M CNY
Revenue Growth
+7.98%
P/S Ratio
4.26
Revenue / Employee
892.63K CNY
Employees
32
Market Cap
135.37M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 28.56M | 2.11M | 7.98% |
| Dec 31, 2024 | 26.45M | 5.03M | 23.47% |
| Dec 31, 2023 | 21.43M | 8.34M | 63.67% |
| Dec 31, 2022 | 13.09M | -70.51M | -84.34% |
| Dec 31, 2021 | 83.60M | 538.00K | 0.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WuXi XDC Cayman | 6.61B |
| Adicon Holdings | 2.94B |
| Kindstar Globalgene Technology | 1.04B |
| Yunkang Group | 669.23M |
| Mega Genomics | 275.03M |
| Biosino Bio-Technology and Science Incorporation | 205.08M |
| Guanze Medical Information Industry (Holding) | 98.42M |
| King International Investment | 77.50M |